A functional tumor-specific immune response was confirmed by the presence of a discrete population of CD8+ T cells positive for CD107 and IFN-γ in mice treated with ivermectin plus anti-PD1, but not in mice treated with anti-PD1 alone or untreated controls (p < 0.01; Fig. 3E, F). This evidence concerns the gene IFNG and neoplasm.